Clinical and Experimental Hepatology
eISSN: 2449-8238
ISSN: 2392-1099
Clinical and Experimental Hepatology
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
Share:
Send email
Share:
Original paper

Hepatitis E virus infection in a single center in Japan

Kohei Ashina
1
,
Hidehiro Kamezaki
2
,
Nana Yamada
2
,
Terunao Iwanaga
2
,
Takafumi Sakuma
2
,
Koji Takahashi
2
,
Junichi Senoo
2

  1. Department of Respiratory Medicine, Eastern Chiba Medical Center, Chiba, Japan
  2. Department of Gastroenterology, Eastern Chiba Medical Center, Chiba, Japan
Clin Exp HEPATOL 2026; 12, 1
DOI: https://doi.org/10.5114/ceh.2026.158807
Online publish date: 2026/02/06
Article file
- Hepatitis E virus.pdf  [0.09 MB]
Get citation
 
PlumX metrics:
 
1. World Health Organization. Hepatitis E. Fact sheets. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-e (accessed: June 30, 2025).
2. Li P, Zheng Y, Chen M, et al. Global prevalence of hepatitis E virus infection: A systematic review and meta-analysis. Liver Int 2020; 40: 1516-1528.
3. Dalton HR, Bendall R, Ijaz S, et al. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709.
4. Kanayama A, Arima Y, Yamagishi T, et al. Epidemiology of domestically acquired hepatitis E virus infection in Japan: Assessment of the nationally reported surveillance data, 2007–2013. J Med Microbiol 2015; 64: 752-758.
5. Sakata H, Matsubayashi K, Iida J, et al. Trends in hepatitis E virus infection: analyses of the long-term screening of blood donors in Hokkaido, Japan, 2005–2019. Transfusion 2021; 61: 3390-3401.
6. Tanaka A, Matsubayashi K, Odajima T, et al. Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion-transmitted infection in Japan. Transfusion 2024; 64: 335-347.
7. Takeda H, Matsubayashi K, Sakata H, et al. A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010; 99: 307-313.
8. Suzuki K, Aikawa T, Okamoto H. Fulminant hepatitis E in Japan. N Engl J Med 2002; 347: 1456.
9. Mizuo H, Yazaki Y, Sugawara K, et al. Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan. J Med Virol 2005; 76: 341-349.
10. Takahashi M, Tamura K, Hoshino Y, et al. A nationwide survey of hepatitis E virus infection in the general population of Japan. J Med Virol 2010; 82: 271-281.
11. Dalton HR, Stableforth W, Thurairajah P, et al. Autochthonous hepatitis E in Southwest England: natural history, complications and seasonal variation. Eur J Gastroenterol Hepatol 2008; 20: 784-790.
12. Sugiyama A, Kurisu A, Tsuji T, et al. Distribution of FIB-4 index in the general population: analysis of 75,666 residents. BMC Gastroenterol 2022; 22: 241.
13. Higashiura Y, Tanaka M, Mori K, et al. High fibrosis-4 index predicts the new onset of ischaemic heart disease during a 10-year period in a general population. Eur Heart J Open 2022; 2: oeac030.
14. Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E virus infection. Clin Microbiol Rev 2014; 27: 116-138.
15. Wedemeyer H, Pischke S, Manns MP. Pathogenesis and treatment of hepatitis E virus infection. Gastroenterology 2012; 142: 1388-1397.e1.
16. Kanda T, Li TC, Takahashi M, et al. Recent advances in hepatitis E virus research and the Japanese clinical practice guidelines for hepatitis E virus infection. Hepatol Res 2024; 54: e1-e30.
Copyright: © Clinical and Experimental Hepatology. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/) enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2026 Termedia Sp. z o.o.
Developed by Termedia.